184
Views
17
CrossRef citations to date
0
Altmetric
Reviews

Molecular diagnosis of hemochromatosis

(Associate Professor of Internal Medicine)
Pages 161-177 | Published online: 23 Jan 2013

Bibliography

  • Simon M, Yaouanq J, Fauchet R, Genetics of hemochromatosis: HLA association and mode of inheritance. Ann NY Acad Sci 1988;526:11-22
  • Feder JN, Gnirke A, Thomas W, A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408
  • Jazwinska EC, Cullen LM, Busfield F, Haemochromatosis and HLA-H. Nat Genet 1996;14:249-51
  • Jouanolle AM, Gandon G, Jezequel P, Haemochromatosis and HLA-H. Nat Genet 1996;14:251-2
  • Robson KJ, Merryweather-Clarke AT, Cadet E, Recent advances in understanding haemochromatosis: a transition state. J Med Genet 2004;41:721-30
  • Piperno A, Sampietro M, Pietrangelo A, Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998;114:996-1002
  • Borot N, Roth M, Malfroy L, Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients. Immunogenetics 1997;45:320-4
  • The Human Gene Mutation Database (HGMD®) Professional. 2012.Institute of medical genetics in cardiff. Available from: http://www.hgmd.cf.ac.uk/ac/index.php
  • Camaschella C, Roetto A, Cali A, The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000;25:14-15
  • Montosi G, Donovan A, Totaro A, Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001;108:619-23
  • Papanikolaou G, Samuels ME, Ludwig EH, Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004;36:77-82
  • Roetto A, Papanikolaou G, Politou M, Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003;33:21-2
  • De Domenico I, Ward DM, Kaplan J. Hepcidin and ferroportin: the new players in iron metabolism. Semin Liver Dis 2011;31:272-9
  • Muckenthaler MU. Fine tuning of hepcidin expression by positive and negative regulators. Cell Metab 2008;8:1-3
  • Andrews NC. Forging a field: the golden age of iron biology. Blood 2008;112:219-30
  • Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol 2001;154:193-206
  • Camaschella C, Roetto A. TFR2-Related hereditary hemochromatosis. In: Pagon RA, Bird TD, Dolan CR, editors. Genereviews. GeneReview™ [Internet]; Seattle (WA): University of Washington, Seattle: 1993-2005; updated 2011
  • Goldberg YP. Juvenile hereditary hemochromatosis. In: Pagon RA, Bird TD, Dolan CR, editors. Genereviews. GeneReview™ [Internet]; Seattle (WA): University of Washington, Seattle: 1993-2005; updated 2011
  • Fracanzani AL, Piperno A, Valenti L, Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors. Hepatology 2010;51:501-10
  • Riva A, Trombini P, Mariani R, Revaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome. World J Gastroenterol 2008;14:4745-52
  • Gordeuk VR. African iron overload. Semin Hematol 2002;39:263-9
  • Steiner M, Leiendecker-Foster C, McLaren GD, Hemochromatosis (HFE) gene splice site mutation IVS5+1 G/A in North American Vietnamese with and without phenotypic evidence of iron overload. Transl Res 2007;149:92-5
  • Powell EE, Ali A, Clouston AD, Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology 2005;129:1937-43
  • Adams PC, Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings. Hepatology 1996;23:724-7
  • Deugnier Y, Brissot P, Loreal O. Iron and the liver: update 2008. J Hepatol 2008;48(Suppl 1):S113-23
  • Merryweather-Clarke AT, Cadet E, Bomford A, Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet 2003;12:2241-7
  • Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 2010;139:393-408; 08 e1-2
  • Adams P, Brissot P, Powell LW. EASL International consensus conference on haemochromatosis. J Hepatol 2000;33:485-504
  • Deugnier YM, Loreal O, Turlin B, Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992;102:2050-9
  • Cecchetti G, Binda A, Piperno A, Cardiac alterations in 36 consecutive patients with idiopathic haemochromatosis: polygraphic and echocardiographic evaluation. Eur Heart J 1991;12:224-30
  • McClain DA, Abraham D, Rogers J, High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia 2006;49:1661-9
  • Carroll GJ, Breidahl WH, Bulsara MK, Hereditary hemochromatosis is characterized by a clinically definable arthropathy that correlates with iron load. Arthritis Rheum 2011;63:286-94
  • Hover AR, McDonnell SM, Burke W. Changing the clinical management of hereditary hemochromatosis: translating screening and early case detection strategies into clinical practice. Arch Intern Med 2004;164:957-61
  • Jacobs EM, Verbeek AL, Kreeftenberg HG, Changing aspects of HFE-related hereditary haemochromatosis and endeavours to early diagnosis. Neth J Med 2007;65:419-24
  • De Gobbi M, Roetto A, Piperno A, Natural history of juvenile haemochromatosis. Br J Haematol 2002;117:973-9
  • Mayr R, Janecke AR, Schranz M, Ferroportin disease: a systematic meta-analysis of clinical and molecular findings. J Hepatol 2010;53:941-9
  • Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis 2004;32:131-8
  • Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011;117:4425-33
  • Camaschella C. Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. Blood 2005;106:3710-17
  • Piperno A, Mariani R, Trombini P, Hepcidin modulation in human diseases: from research to clinic. World J Gastroenterol 2009;15:538-51
  • Qiao B, Sugianto P, Fung E, Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab 2012;15:918-24
  • De Domenico I, Ward DM, Musci G, Iron overload due to mutations in ferroportin. Haematologica 2006;91:92-5
  • Piperno A, Girelli D, Nemeth E, Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood 2007;110:4096-100
  • Pietrangelo A. Hemochromatosis: an endocrine liver disease. Hepatology 2007;46:1291-301
  • Witte DL, Crosby WH, Edwards CQ, Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 1996;245:139-200
  • Felitti VJ, Beutler E. New developments in hereditary hemochromatosis. Am J Med Sci 1999;318:257-68
  • Beutler E, Felitti VJ, Koziol JA, Penetrance of 845G–> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-18
  • McCune CA, Al-Jader LN, May A, Hereditary haemochromatosis: only 1% of adult HFEC282Y homozygotes in South Wales have a clinical diagnosis of iron overload. Hum Genet 2002;111:538-43
  • Phatak PD, Ryan DH, Cappuccio J, Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients. Blood Cells Mol Dis 2002;29:41-7
  • Allen KJ, Gurrin LC, Constantine CC, Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 2008;358:221-30
  • Pedersen P, Milman N. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants. Ann Hematol 2009;88:775-84
  • Gurrin LC, Bertalli NA, Dalton GW, HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity. Hepatology 2009;50:94-101
  • Gleeson F, Ryan E, Barrett S, Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening. Eur J Gastroenterol Hepatol 2004;16:859-63
  • Olynyk JK, Cullen DJ, Aquilia S, A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718-24
  • Piperno A, Mariani R, Arosio C, Haemochromatosis in patients with beta-thalassaemia trait. Br J Haematol 2000;111:908-14
  • Laine F, Jouannolle AM, Morcet J, Phenotypic expression in detected C282Y homozygous women depends on body mass index. J Hepatol 2005;43:1055-9
  • Walsh A, Dixon JL, Ramm GA, The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Clin Gastroenterol Hepatol 2006;4:1403-10
  • Aguilar-Martinez P, Bismuth M, Picot MC, Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut 2001;48:836-42
  • Beutler E. The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet 1997;61:762-4
  • Castiella A, Zapata E, de Juan MD, Significance of H63D homozygosity in a Basque population with hemochromatosis. J Gastroenterol Hepatol 2010;25:1295-8
  • Tomatsu S, Orii KO, Fleming RE, Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis. Proc Natl Acad Sci USA 2003;100:15788-93
  • Le Gac G, Congiu R, Gourlaouen I, Homozygous deletion of HFE is the common cause of hemochromatosis in Sardinia. Haematologica 2010;95:685-7
  • Pelucchi S, Mariani R, Bertola F, Homozygous deletion of HFE: the Sardinian hemochromatosis? Blood 2009;113:3886
  • Takano A, Niimi H, Atarashi Y, A novel Y231del mutation of HFE in hereditary haemochromatosis provides in vivo evidence that the Huh-7 is a human haemochromatotic cell line. Liver Int 2011;31:1593-7
  • Aguilar-Martinez P, Grandchamp B, Cunat S, Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants. Haematologica 2011;96:507-14
  • Mariani R, Pelucchi S, Arosio C, Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes. Blood Cells Mol Dis 2010;44:159-63
  • Piperno A. Classification and diagnosis of iron overload. Haematologica 1998;83:447-55
  • Lanzara C, Roetto A, Daraio F, Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 2004;103:4317-21
  • Koyama C, Hayashi H, Wakusawa S, Three patients with middle-age-onset hemochromatosis caused by novel mutations in the hemojuvelin gene. J Hepatol 2005;43:740-2
  • Pietrangelo A. Hereditary hemochromatosis. Ann Rev Nutr 2006;26:251-70
  • Le Gac G, Mons F, Jacolot S, Early onset hereditary hemochromatosis resulting from a novel TFR2 gene nonsense mutation (R105X) in two siblings of north French descent. Br J Haematol 2004;125:674-8
  • Piperno A, Roetto A, Mariani R, Homozygosity for transferrin receptor-2 Y250X mutation induces early iron overload. Haematologica 2004;89:359-60
  • Girelli D, Bozzini C, Roetto A, Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. Gastroenterology 2002;122:1295-302
  • Pelucchi S, Mariani R, Trombini P, Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2. Haematologica 2009;94:276-9
  • Roetto A, Totaro A, Piperno A, New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 2001;97:2555-60
  • Le Lan C, Mosser A, Ropert M, Sex and acquired cofactors determine phenotypes of ferroportin disease. Gastroenterology 2011;140:1199-207 e1-2
  • Pelucchi S, Mariani R, Salvioni A, Novel mutations of the ferroportin gene (SLC40A1): analysis of 56 consecutive patients with unexplained iron overload. Clin Genet 2008;73:171-8
  • EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol 2010;53:3-22
  • Bacon BR, Adams PC, Kowdley KV, Diagnosis and management of hemochromatosis: 2011 practice guidelines by the American association for the study of liver diseases. Hepatology 2011(54(1):328-43
  • King C, Barton DE. Best practice guidelines for the molecular genetic diagnosis of Type 1 (HFE-related) hereditary haemochromatosis. BMC Med Genet 2006;7:81
  • Edwards CQ, Griffen LM, Ajioka RS, Screening for hemochromatosis: phenotype versus genotype. Semin Hematol 1998;35:72-6
  • Guyader D, Jacquelinet C, Moirand R, Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998;115:929-36
  • McLaren CE, McLachlan GJ, Halliday JW, Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology 1998;114:543-9
  • Porto G, Vicente C, Fraga J, Importance of establishing appropriate local reference values for the screening of hemochromatosis: a study of three different control populations and 136 hemochromatosis family members. Hemochromatosis Clinical and Research Group. J Lab Clin Med 1992;119:295-305
  • Pietrangelo A, Caleffi A, Corradini E. Non-HFE hepatic iron overload. Semin Liver Dis 2011;31:302-18
  • Milman N, Byg KE, Ovesen L, Iron status in Danish men 1984-94: a cohort comparison of changes in iron stores and the prevalence of iron deficiency and iron overload. Eur J Haematol 2002;68:332-40
  • Milman N, Byg KE, Ovesen L. Iron status in Danes 1994. II: prevalence of iron deficiency and iron overload in 1319 Danish women aged 40-70 years. Influence of blood donation, alcohol intake and iron supplementation. Ann Hematol 2000;79:612-21
  • Aguilar-Martinez P, Schved JF, Brissot P. The evaluation of hyperferritinemia: an updated strategy based on advances in detecting genetic abnormalities. Am J Gastroenterol 2005;100:1185-94
  • Camaschella C, Poggiali E. Towards explaining "unexplained hyperferritinemia". Haematologica 2009;94:307-9
  • Trombini P, Piperno A. Ferritin, metabolic syndrome and NAFLD: elective attractions and dangerous liaisons. J Hepatol 2007;46:549-52
  • Angelucci E, Brittenham GM, McLaren CE, Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 2000;343:327-31
  • Christoforidis A, Perifanis V, Spanos G, MRI assessment of liver iron content in thalassamic patients with three different protocols: comparisons and correlations. Eur J Haematol 2009;82:388-92
  • Gandon Y, Olivie D, Guyader D, Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004;363:357-62
  • Kirk P, He T, Anderson LJ, International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imaging 2010;32:315-19
  • St Pierre TG, Clark PR, Chua-anusorn W, Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105:855-61
  • Bassett ML, Hickman PE, Dahlstrom JE. The changing role of liver biopsy in diagnosis and management of haemochromatosis. Pathology 2011;43:433-9
  • Allen KJ, Bertalli NA, Osborne NJ, HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis. Hepatology 2010;52:925-33
  • Piperno A, Fargion S, D'Alba R, Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection. J Hepatol 1992;16:364-8
  • Castiella A, Zapata E, Alustiza JM. Non-invasive methods for liver fibrosis prediction in hemochromatosis: one step beyond. World J Hepatol 2010;2:251-5
  • Castera L, Pinzani M. Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut 2010;59:861-6
  • Fraquelli M, Cassinerio E, Roghi A, Transient elastography in the assessment of liver fibrosis in adult thalassemia patients. Am J Hematol 2010;85:564-8
  • Di Marco V, Bronte F, Cabibi D, Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition. Br J Haematol 2010;148:476-9
  • Adhoute X, Foucher J, Laharie D, Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study. Gastroenterol Clin Biol 2008;32:180-7
  • Deugnier Y, Turlin B. Pathology of hepatic iron overload. Semin Liver Dis 2011;31:260-71
  • Bryant J, Cooper K, Picot J, A systematic review of the clinical validity and clinical utility of DNA testing for hereditary haemochromatosis type 1 in at-risk populations. J Med Genet 2008;45:513-18
  • Mura C, Raguenes O, Ferec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 1999;93:2502-5
  • Arya N, Chakrabrati S, Hegele RA, HFE S65C variant is not associated with increased transferrin saturation in voluntary blood donors. Blood Cells Mol Dis 1999;25:354-7
  • Altes A, Ruiz A, Barcelo MJ, Prevalence of the C282Y, H63D, and S65C mutations of the HFE gene in 1,146 newborns from a region of Northern Spain. Genet Test 2004;8:407-10
  • Camaschella C, Roetto A, De Gobbi M. Juvenile hemochromatosis. Semin Hematol 2002;39:242-8
  • Gehrke SG, Pietrangelo A, Kascak M, HJV gene mutations in European patients with juvenile hemochromatosis. Clin Genet 2005;67:425-8
  • Huang FW, Rubio-Aliaga I, Kushner JP, Identification of a novel mutation (C321X) in HJV. Blood 2004;104:2176-7
  • Porto G, Roetto A, Daraio F, A Portuguese patient homozygous for the -25G> A mutation of the HAMP promoter shows evidence of steady-state transcription but fails to up-regulate hepcidin levels by iron. Blood 2005;106:2922-3
  • Mendler MH, Turlin B, Moirand R, Insulin resistance-associated hepatic iron overload. Gastroenterology 1999;117:1155-63
  • Turlin B, Mendler MH, Moirand R, Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients. Am J Clin Pathol 2001;116:263-70
  • El-Serag HB, Inadomi JM, Kowdley KV. Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis. Ann Intern Med 2000;132:261-9
  • Adams PC, Gregor JC, Kertesz AE, Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database. Gastroenterology 1995;109:177-88
  • Bryant J, Cooper K, Picot J, Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation. Health Technol Assess 2009;13: iii, ix-xi 1-126
  • Constantine CC, Anderson GJ, Vulpe CD, A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis. Br J Haematol 2009;147:140-9
  • Cruz E, Whittington C, Krikler SH, A new 500 kb haplotype associated with high CD8+ T-lymphocyte numbers predicts a less severe expression of hereditary hemochromatosis. BMC Med Genet 2008;9:97
  • Milet J, Dehais V, Bourgain C, Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance. Am J Hum Genet 2007;81:799-807
  • Pelucchi S, Mariani R, Calza S, CYBRD1 as a modifier gene that modulates iron phenotype in HFEp.c282y homozygous patients. Haematologica 2012;97:1818-25
  • Deugnier Y, Turlin B, le Quilleuc D, A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis. Am J Surg Pathol 1997;21:669-75
  • Ludwig J, Hashimoto E, Porayko MK, Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997;112:882-8
  • Crawford DH, Halliday JW, Summers KM, Concordance of iron storage in siblings with genetic hemochromatosis: evidence for a predominantly genetic effect on iron storage. Hepatology 1993;17:833-7
  • Delatycki MB, Powell LW, Allen KJ. Hereditary hemochromatosis genetic testing of at-risk children: what is the appropriate age? Genet Test 2004;8:98-103
  • Voelkerding KV, Dames S, Durtschi JD. Next generation sequencing for clinical diagnostics-principles and application to targeted resequencing for hypertrophic cardiomyopathy: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn 2010;12:539-51

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.